- Home
- ESEA vs INMB Comparison
ESEA vs INMB Comparison
Compare ESEA & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- INMB
- Stock Information
- Founded
- ESEA 2005
- INMB 2015
- Country
- ESEA Greece
- INMB United States
- Employees
- ESEA N/A
- INMB N/A
- Industry
- ESEA Marine Transportation
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- ESEA Consumer Discretionary
- INMB Health Care
- Exchange
- ESEA Nasdaq
- INMB Nasdaq
- Market Cap
- ESEA 208.2M
- INMB 176.5M
- IPO Year
- ESEA 2006
- INMB 2019
- Fundamental
- Price
- ESEA $44.94
- INMB $6.38
- Analyst Decision
- ESEA
- INMB Strong Buy
- Analyst Count
- ESEA 0
- INMB 3
- Target Price
- ESEA N/A
- INMB $24.33
- AVG Volume (30 Days)
- ESEA 29.6K
- INMB 627.1K
- Earning Date
- ESEA 06-18-2025
- INMB 07-31-2025
- Dividend Yield
- ESEA 5.80%
- INMB N/A
- EPS Growth
- ESEA 21.86
- INMB N/A
- EPS
- ESEA 18.62
- INMB N/A
- Revenue
- ESEA $222,525,034.00
- INMB $50,000.00
- Revenue This Year
- ESEA $5.14
- INMB $82.14
- Revenue Next Year
- ESEA $3.76
- INMB $28,750.98
- P/E Ratio
- ESEA $2.45
- INMB N/A
- Revenue Growth
- ESEA 14.62
- INMB N/A
- 52 Week Low
- ESEA $24.58
- INMB $4.32
- 52 Week High
- ESEA $50.82
- INMB $10.50
- Technical
- Relative Strength Index (RSI)
- ESEA 87.76
- INMB 37.45
- Support Level
- ESEA $42.47
- INMB $6.68
- Resistance Level
- ESEA $50.82
- INMB $8.05
- Average True Range (ATR)
- ESEA 1.59
- INMB 0.62
- MACD
- ESEA 0.38
- INMB -0.10
- Stochastic Oscillator
- ESEA 66.24
- INMB 10.31
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.